AOD9604 is a fragment of human growth hormone deliberately chosen to separate one property of the hormone from the rest of its activity.

What Is AOD9604?

Human growth hormone is a 191-amino-acid protein. AOD9604 corresponds to residues 176 to 191 — the C-terminal region — with an additional tyrosine at the N-terminus for stability.

The selection is not arbitrary. Growth hormone’s receptor-binding surfaces, and therefore its receptor-binding and IGF-1-stimulating activity, reside in other regions of the molecule. Research had reported activity of the C-terminal fragment in lipid-metabolism assays independent of these. AOD9604 is an attempt to isolate that property.

How Researchers Understand Its Mechanism

What AOD9604 does not do is as well established as what it does. Studies have consistently reported that it does not bind or activate the growth hormone receptor and does not raise IGF-1 expression in model systems. This is the defining experimental control: any observed effect cannot be attributed to growth hormone receptor signaling.

What research has reported concerns adipocyte metabolism, with changes described in the activity of lipid-metabolising enzymes in cultured adipocytes. The mechanism is not fully resolved and no specific receptor has been identified, though beta-3 adrenergic involvement has been proposed and remains debated.

The gap between clearly excluded mechanisms and a positively identified one is characteristic of this compound and should inform how the literature is read.

Areas of Scientific Investigation

Applications include adipocyte metabolism assays, enzyme activity measurement, growth hormone fragment structure-function research, and control experiments requiring a growth hormone-derived sequence without receptor activity.

Why Purity and Verification Matter

Reproducibility in peptide research depends on knowing exactly what is in the vial. Sequence-related impurities, truncated fragments and residual synthesis reagents can all influence experimental outcomes, and two preparations nominally of the same compound can behave differently if purity differs. Independent HPLC and mass spectrometry testing establishes both identity and purity, which is why third-party verification is standard practice for research-grade material. All compounds referenced here are supplied as lyophilized powder at 99%+ purity with independent verification.

Summary

AOD9604 is the 176-191 fragment of human growth hormone with an added N-terminal tyrosine, notable for lacking growth hormone receptor activity and IGF-1 effects while retaining reported activity in cultured adipocyte models. Its positive mechanism remains unresolved. It is intended strictly for laboratory research.

Related Research Peptides

AOD9604 5mg · AOD9604 10mg · Tesamorelin 5mg · Sermorelin 10mg · 5-Amino-1MQ 10mg

For laboratory and research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.